Retinal infections caused by the varicella-zoster virus (VZV) have been reported in immunocompetent and immunocompromised individuals. Two cases of a VZV related retinitis are described with the characteristic
(e) Peripheral retina of the left eye. Some areas of apparently uninvolved retina can be seen along some retinal vessels (arrow).
his right eye was 6/6, and 1160 in his left eye. The anterior segments were both quiet and the intra ocular pressures were 10 mmHg in each eye. Examination of the retina revealed a parafoveal, white lesion of the outer retina in the right eye (Fig.  la) . There was a white lesion at the left macula, one disc diameter in size, with a central cherry-red spot (Fig. lb) . Both optic discs were swollen but the periphery of each retina was completely normal. The differential diagnosis of bilateral outer retinitis with swollen optic discs includes atypical presentation of CMV retinitis, cryptococcal retinitis (with possible reactivation of meningitis), toxo plasma retinitis, zoster retinitis and primary central nervous system lymphoma. A lumbar puncture and computed tomography (CT) scan of the brain were therefore performed, but did not reveal active intracranial infection or evidence of raised intracra nial pressure. A vitreous biopsy taken at presenta tion revealed the presence of VZV DNA only, with no evidence of either CMV or HSV-l DNA (see Methods).
The retinitis was initially managed with intrave nous (IV) acyclovir (10 mg/kg three times per day) in combination with IV foscamet (60 mg/kg three times per day). The lesions in both eyes progressed despite therapy, with the appearance of new satellite lesions which became confluent around the central lesions in both eyes (Figs. lc, d ). After 1 week visu. al acuity of the right eye was reduced to 6/12 due to enlargement of the central lesion. On the tenth day, multiple areas of retinitis developed in the mid-periphery and periphery of the left eye, which were shortly followed by the development of a supero-temporal retinal detachment. The vitreous was attached and no cells could be seen in either eye.
Argon laser photocoagulation was undertaken in an attempt to limit the progression of the left retinal detachment. An intravitreal injection of 0.2 mg! 0.1 ml of acyclovir was given in the right eye. After 48 hours the dose of acyclovir was increased to 20 mg/kg three times per day IV, and daily injections of intra vitreal acyclovir for 1 week were commenced.
One week later, the lesions in both eyes were less active and the optic discs were no longer swollen; the retina at the posterior pole remained attached in the left eye and clear, non-opacified areas of retina could be seen along the retinal vessels in the periphery of this eye (Fig. le) . After 3 weeks, the dose of IV acyclovir was reduced to 15 mg/kg three times per day, and then to 10 mg/kg three times per day after a further week.
Problems with the patient's central venous indwel ling catheter led to replacement of the IV treatment with oral acyclovir 800 mg five times per day. After another 2 weeks, the retinitis reactivated in both eyes with the development of peripheral lesions in the 273 right eye, and progression of the retinal detachment in the left eye. Intravenous therapy was therefore reintroduced. However, a retinal detachment devel oped in· the right eye and the left eye lost light perception due to continued disease resulting in complete retinal detachment.
The right retina was re-attached following vitrec tomy, retinotomy, endolaser and silicone oil, result ing in a visual acuity of 6/60 and a very restricted visual field. At this stage the patient elected to discontinue with IV treatment and when next seen this eye had also lost light perception. He subse quently decided to stop all medical treatment and died within a few weeks. Authorisation to obtain his eyes at post-mortem was not obtained. A 37-year-old white homosexual male presented with a 10 day history of acute, profound loss of vision in his right eye, without any other symptoms. He was HIV antibody positive and had been diagnosed as having AIDS 1 year before developing ocular symptoms. Left CMV retinitis had been diagnosed 5 days previously and he had commenced an induction course of IV ganciclovir (5 mg/kg twice a day). There were no previous ophthalmic problems. His ophthalmic presentation coincided with a sudden drop in his �eripheral blood CD4+ T lymphocytes to 14 cells/mm .
On examination of the eyes his visual acuity was light perception with accurate projection in the right eye and 6/6 in the left eye. There was a low-grade right anterior uveitis and a mild bilateral vitritis. His right intraocular pressure was 5 mmHg and the left was 8 mmHg. The right fundus showed a large white lesion at the right macula (Fig. 2a) , with multiple, white, outer retinal lesions in the periphery and mid periphery.
In the left eye there were two areas of typical active CMV retinitis in the supero-nasal and infero temporal quadrants but no other retinal lesions. Both optic discs appeared normal. Cerebrospinal fluid was normal on lumbar puncture, and VZV DNA was identified by PCR from a vitreous biopsy of the right eye, with no evidence of CMV or HSV-l DNA. Vitreous biopsy from the left eye revealed only CMV DNA. A diagnosis of PORN in the right eye was considered ' and high-dose IV acyclovir (20 mg/kg three times per day) was commenced. A course of four intravitreal injections of acyclovir (0.2 mg! 0.1 ml) was given during the first 2 weeks of treatment.
The peripheral lesions became more prominent in the right eye, and laser demarcation was not attempted due to the widespread distribution of retinal lesions. An area of retinal traction developed in the supero-temporal quadrant of the right eye after a few days, at the same time as a space of non opacified (,normal' -looking) retina could be seen along the retinal vessels. The left CMV retinitis improved and the dose of ganciclovir was reduced to maintenance (one daily dose, 7 days per week) after 3 weeks. There were no signs of outer retinitis in this eye. The macular retinitis in the right eye showed improvement after 13 days of therapy (Fig. 2b) , but the peripheral retinitis progressed with the develop ment of multiple retinal breaks which led to inferior and, subsequently, total retinal detachment. In view of the poor visual prognosis in this eye, retinal reattachment surgery was not undertaken. The left CMV retinitis became quiescent and prophylactic laser photocoagulation was applied around the areas of scar due to the presence of a still attached vitreous and retinal traction in those areas. The patient continued taking IV acyclovir indefinitely (10 mg/ kg three times per day initially and subsequently twice a day).
The left eye had several recurrences of CMV retinitis which reduced visual acuity to 6/36. His general condition deteriorated progressively and the patient died in December 1993, 1 year after his ophthalmic presentation. Up to his death there were no signs of PORN in the left eye.
METHOD FOR DETECTION OF HERPES VIRAL DNA IN VITREOUS FLUID
The nested polymerase chain reaction (PCR) method used for the detection of viral DNA sequences from CMV gene gB, VZV gene 29 and HSV -1 gD has been described previously 6 and was applied to the detection of cell-free vitreous samples from the patients described. minutes 50-60°C for 2 minutes and 72 °C for 1 minute were carried out, followed by a 7 minute extension at 72 °C using an automated thermal cycler. The reaction conditions for the second round of PCR were as for the first except that the mix contained 100 ng of each 'inner' primer pair and 1 f.LI of the first-round product. Twenty-five cycles were sufficient for the detection of the second-round product. First-and second-round products were analysed by electrophoresis using a 2 % agarose gel, and products were visualised at 302 nm after staining by ethidium bromide.
DISCUSSION
The progressive outer retinal necrosis syndrome (PORN), as recently described in two reports, 4 , 5 appears to be caused by VZV. It is a new disease characterised by early macular retinitis in the presence of little or no intraocular' inflammation.
There is rapid progression with the development of lesions in the mid and peripheral retina. The optic nerve may become involved at any stage of the disease. With progression there is clearing of areas along retinal vessels, which has been described as a 'cracked mud' appearance by some authors. 5 Retinal vasculitis appears quite late in the disease course. The appearance is quite distinct from acute retinal necrosis (ARN), in which VZV has also been implicated, and which has also been reported in immunocompromised patients,1O,11 including those with AIDSy,12 In ARN the striking feature is a peripheral retinitis which becomes confluent and is usually associated with intense vitreous and anterior chamber reaction even if the patient is immunosup pressed.
The reason for a different presentation in the PORN cases compared with the cases of ARN is not clear. It may be that there is a more profound degree of immunosuppression or a different strain of VZV. The two patients described in this report had very low levels of circulating peripheral blood CD4+ T lymphocytes, as in previous reports. ARN is sufficiently infrequent in patients with AIDS to not allow any conclusions to be drawn regarding peripheral CD4+ T lymphocyte numbers in these patients. It is possible that a higher level of immunity may be associated with a more aggressive immune reaction producing the clinical syndrome of ARN, while patients with more profound immunosuppres sion in AIDS may result in the features of PORN. Some cases of ARN described in immunocompetent hosts follow a less aggressive course, with limited peripheral retinitis and good visual outcome,13 which could be due to infection with a different strain of virus. ARN associated with varicella has a better prognosis. 14 The first patient was initially managed with IV foscarnet (90 mg/kg twice a day) and IV acyclovir, using the recommended clinical dose (10 mg/kg three times per day). The decision to increase the dose of acyclovir to twice the conventional level was made as the normal level of acyclovir therapy had proved ineffective in preventing progression of the disease in other patients (Todd Margolis, personal communica tion). It is possible that the retinal ischaemia engendered by this infection precludes the achieve ment of therapeutic levels of acyclovir in the retina. The first patient with bilateral disease at presentation had a good initial response to the higher level of IV acyclovir. This patient deteriorated only when therapy was changed to the oral route of adminis tration. The second patient was treated intravenously from presentation (12 months) and did not show any signs of zoster retinitis in his left eye until his death. The dose of acyclovir was reduced to the usual levels of therapy after 3 months at the higher dose. The experience from these two patients suggests that this higher level of acyclovir might be capable of controlling the progression of the zoster retinitis, but further experience is obviously required. In a series of five cases of presumed varicella-zoster retinopathy recently reported, the authors have also 275 used IV acyclovir, both in normal and in high concentrations (14 mg/kg and 22 g/kg three times per day).lS Three of their patients received IV foscarnet, and in one of them IV ganciclovir was also used. They report stabilisation of the disease in a median time of 51 days, but similar to our experience there was recurrence of the disease once oral acyclovir was used as maintenance therapy. It is also important to investigate the role of intravitreal injections of acyclovir and even foscarnet in the control of the acute presentation of the disease. The efficiency of this regimen in preventing the involve ment of the second eye in unilateral presenting cases is questionable and the experience from more cases will be necessary to answer this question.
Even though acyclovir has been found to be more active against HSV types 1 and 2 (IDso 0.1-1.6 j.LM) than VZV (IDso 3-4 j.LM) in vitro, 16 it is recognised as the drug of choice for the treatment of herpes zoster in immunocompromised patientsp, 18 Recur rence has been reported in patients who switched from intravenous to oral medication, as well as in situations of tapering of oral therapy,lS as observed in our first patient. These patients require chronic suppressive antiviral therapy which carries the potential risk for the development of acyclovir resistant varicella-zoster strains, necessitating the use of other antiviral drugs such as foscarnet. 19 In the search for new antiviral drugs efforts have been concentrated in the development of increased bioavailability prodrugs such as famciclovir. This prodrug of penciclovir is converted to the active drug once absorbed, enabling high serum levels, and potentially increasing efficacy in herpes simplex and VZV-induced diseases,z o The benefits of using this drug in cases of PORN have yet to be evaluated. Rapid control of the progression of the infection is of great importance due to the destructive nature of the inflammation and the high propensity for the retina to detach. Early introduction of high-dose IV acyclovir, especially in unilateral cases, may offer the best treatment option available at present. Such high levels of IV acyclovir demand close monitoring of renal function, and patients need an increase in total fluid intake. Intravitreal injection of antiviral drugs to avoid drug-delivery problems due to ischaemia could also be very important in the management of these cases.
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